Article

Spasticity is a complex condition and its management is multifaceted, involving
physical therapies as well as interventions with botulinum toxin. There is
currently no standard for best practice and also wide variation in spasticity
service set-ups and the background of clinicians involved in treatment. This
could potentially cause large differences in practice.
The aim of this survey was
to attempt to identify some of the common elements of service delivery as well as
highlight any significant variations in service models. It was hoped that the
results would assist healthcare professionals working with toxins to gauge or
improve their own service provision in the light of any findings. A survey of 48
botulinum toxin experts was conducted at a national conference in the UK.
Questions included (i) numbers of patients referred and diagnostic groups, (ii)
staff composition of each clinic, (iii) methods of spasticity assessment, (iv)
outcome measures and treatment goals commonly used and (v) follow-up
arrangements. There were broad areas of agreement between experts such as methods
of assessment of spasticity, treatment, injection guidance and follow-up
arrangements. However, there were differences in diagnostic groups seen, staff
composition and in outcome measurement across a wide range of clinic settings.
There are considerable variations in practice between toxin experts. This survey
may help practitioners identify areas of improvement in their services or explore alternative service arrangements.

Langue : ANGLAIS